AtriCure to Announce Fourth Quarter and Full Year 2025 Financial Results
AtriCure (NASDAQ:ATRC) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026 [Yahoo! Finance]
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026
AtriCure (ATRC): Assessing Valuation After First-In-Human PFA/RFA Procedures and Renewed Analyst Optimism [Yahoo! Finance]